Key result
Diabetes linked to ~325% higher major cardiovascular events and mortality risk, especially with LV dysfunction.
Why the study?
The role of diabetes in the long-term prognosis of patients with ischemic cardiomyopathy and severe left ventricular dysfunction was unknown.
Does the presence of diabetes mellitus worsen long-term outcomes in patients with ischemic cardiomyopathy?
Cohort (n=918)
No
Does the presence of diabetes mellitus worsen long-term outcomes in patients with ischemic cardiomyopathy?
In patients with multivessel coronary artery disease, the combination of diabetes and ventricular dysfunction is associated with significantly higher long-term mortality than either condition alone.
Answers are grounded in this paper and cite their sources.
May warrant closer monitoring in diabetic patients with ischemic cardiomyopathy and LV dysfunction; leaves open whether targeted interventions improve outcomes.
Background Patients with ischemic cardiomyopathy and severe left ventricular dysfunction have a worse survival prognosis than patients with preserved ventricular function. The role of diabetes in the long-term prognosis of this patient group is unknown. This study investigated whether the presence of diabetes has a long-term impact on left ventricular function. Methods Patients with coronary artery disease who underwent coronary artery bypass graft surgery, percutaneous coronary intervention, or medical therapy alone were included. All patients had multivessel disease and left ventricular ejection fraction measurements. Overall mortality, nonfatal myocardial infarction, stroke, and additional interventions were investigated. Results From January 2009 to January 2010, 918 consecutive patients were selected and followed until May 2015. They were separated into 4 groups: G1, 266 patients with diabetes and ventricular dysfunction; G2, 213 patients with diabetes without ventricular dysfunction; G3, 213 patients without diabetes and ventricular dysfunction; and G4, 226 patients without diabetes but with ventricular dysfunction. Groups 1, 2, 3, and 4, respectively, had a mortality rate of 21.6, 6.1, 4.2, and 10.6% (P < .001); nonfatal myocardial infarction of 5.3, .5, 7.0, and 2.6% (P < .001); stroke of .40, .45, .90, and .90% (P = NS); and additional intervention of 3.8, 11.7, 10.3, and 2.6% (P < .001). Conclusion In this sample, regardless of the treatment previously received patients with or without diabetes and preserved ventricular function experienced similar outcomes. However, patients with ventricular dysfunction had a worse prognosis compared with those with normal ventricular function; patients with diabetes had greater mortality than patients without diabetes. Trial registration http://www.controlled-trials.com .
No takes yet. Share an insight, caveat, or question.
Hueb et al. (2018) conducted a cohort in Ischemic cardiomyopathy and stable multivessel coronary artery disease (n=918). Diabetes mellitus vs. Patients without diabetes was evaluated on Major adverse cardiac events (overall mortality, nonfatal myocardial infarction, stroke, or refractory angina requiring revascularization) (HR 4.25, 95% CI 3.62-5.65, p=<0.001). The presence of diabetes mellitus increased the risk of major adverse cardiac events and overall mortality, particularly in patients with left ventricular dysfunction.
Synapse has enriched 10 related papers. Consider them for comparative context: